This newsletter highlights how the 2026 cardiovascular–kidney–metabolic (CKM) guideline moves social determinants of health (SDOH) from background context to a central clinical variable in routine care. It focuses on three priority domains—food insecurity, housing instability and financial strain—each recognised as independently increasing the risk of developing CKM syndrome and worsening outcomes once the syndrome is established. The piece also notes the guideline’s explicit inclusion of intimate partner violence and its directive to embed social workers and community health workers within multidisciplinary CKM teams.

Using an illustrative mechanism figure, the newsletter describes how adverse SDOH intersect with biological, behavioural and pharmacological pathways in obesity and CKM, in a population where overweight and obesity are highly prevalent. Clinically, it argues that brief, validated SDOH screening tools should be applied alongside standard tests such as eGFR and UACR, as identifying patients who cannot afford medications or food can alter management as profoundly as abnormal laboratory results. The description emphasises that systematic documentation of social risk supports both individualised treatment planning—through referral pathways and adherence support—and population-health strategies, including equitable allocation of limited specialist and pharmacologic resources.